Clinicopathological and molecular biological characteristics of early-onset stage II/III colorectal adenocarcinoma: An analysis of 25 studies with 47,184 patients (pts) in the adjuvant colon cancer end points (ACCENT) database.

Authors

null

Zhaohui Jin

Mayo Clinic, Rochester, MN

Zhaohui Jin , Jesse G. Dixon , Hiral D. Parekh , Steven R Alberts , Greg Yothers , Carmen Joseph Allegra , Rachel Kerr , Daniel G. Haller , Aimery De Gramont , Takayuki Yoshino , Eric Van Cutsem , Chris Twelves , Julien Taieb , Leonard B. Saltz , Jean-François Seitz , Thierry Andre , Amit Mahipal , Richard M. Goldberg , Qian Shi , Thomas J. George

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2020 ASCO Virtual Scientific Program

Session Type

Poster Session

Session Title

Gastrointestinal Cancer—Colorectal and Anal

Track

Gastrointestinal Cancer—Colorectal and Anal

Sub Track

Colorectal Cancer–Local-Regional Disease

Citation

J Clin Oncol 38: 2020 (suppl; abstr 4099)

DOI

10.1200/JCO.2020.38.15_suppl.4099

Abstract #

4099

Poster Bd #

91

Abstract Disclosures

Similar Posters

Poster

2017 ASCO Annual Meeting

Nut consumption and survival in stage III colon cancer patients: Results from CALGB 89803 (Alliance).

Nut consumption and survival in stage III colon cancer patients: Results from CALGB 89803 (Alliance).

First Author: Temidayo Fadelu

First Author: Julien Taieb

First Author: Erin Van Blarigan